Meka Bharani, Ravada Suryachandra Rao, Murali Krishna Kumar Muthyala, Purna Nagasree Kurre, Golakoti Trimurtulu
Laila Impex R&D Center, Unit-I, Phase-III, Jawahar Auto Nagar, Vijayawada 520 007, Andhra Pradesh, India.
Department of Pharmaceutical Chemistry, AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam 530 00, Andhra Pradesh, India.
Bioorg Med Chem. 2017 Feb 15;25(4):1374-1388. doi: 10.1016/j.bmc.2016.12.045. Epub 2016 Dec 29.
A new series of 11-keto-β-boswellic acid and 3-O-acetyl-11-keto-β-boswellic acid analogs (5, 7, 8, 10, 13, 18a-d, 27a-c, 28a-d) were synthesized by modification of hydroxyl and acid functional moieties of boswellic acids. The structures of these analogs were confirmed by spectral data analysis (H, C NMR and mass). Compounds 18b, 27a and 8 showed potent 5-lipoxygenase enzyme inhibitory activity (IC: 19.53, 20.31 and 44.14μg/mL). The computational studies revealed that selectivity of AKBA is due to its fitment into the 5-LOX receptor, which is missing for the other enzymes like 12-LOX, COX-1 and COX-2. Our study found potentiating effects of 2-formyl and 3-keto substituents in reviving inactive AKBA analogues possessing essential COOH group at 4th position.
通过对乳香酸的羟基和酸官能团进行修饰,合成了一系列新的11-酮基-β-乳香酸和3-O-乙酰基-11-酮基-β-乳香酸类似物(5、7、8、10、13、18a-d、27a-c、28a-d)。通过光谱数据分析(氢谱、碳谱核磁共振和质谱)确定了这些类似物的结构。化合物18b、27a和8表现出强大的5-脂氧合酶抑制活性(半数抑制浓度:19.53、20.31和44.14μg/mL)。计算研究表明,11-酮基-β-乳香酸(AKBA)的选择性是由于其能适配5-脂氧合酶(5-LOX)受体,而其他酶如12-脂氧合酶(12-LOX)、环氧化酶-1(COX-1)和环氧化酶-2(COX-2)则缺少该受体。我们的研究发现,2-甲酰基和3-酮基取代基对恢复在第4位具有必需羧基的无活性AKBA类似物具有增强作用。